We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Breakthrough Ultrasound Technology Measures Blood Viscosity in Real Time

By HospiMedica International staff writers
Posted on 20 Nov 2025

Blood pressure, pulse, temperature, and oxygen levels have long defined the core metrics physicians use to assess health — yet one key indicator has remained out of reach: blood viscosity. More...

Because thicker, slower-moving blood can strain the heart, promote clot formation, and contribute to tissue damage, its impact spans major illnesses, including heart disease, stroke, and cancer. Now, researchers have developed a non-invasive, real-time ultrasound-based technology designed to measure blood viscosity directly inside the body.

The device, developed by researchers at the University of Missouri (Columbia, MO, USA), uses continuous-wave ultrasound to gently vibrate blood and then measures how the signal propagates through the body. Its core innovation lies in advanced mathematical modeling and signal-processing algorithms, which interpret the acoustic response to calculate both blood density and viscosity simultaneously — something not previously possible. Unlike traditional laboratory methods that require drawing blood and can alter its properties, the tool captures viscosity in situ, reflecting the body’s true physiological state.

Originally designed to monitor engine lubricant quality, the technology was adapted for biomedical use after researchers recognized its potential in disease management. Real-time viscosity monitoring could benefit conditions such as sickle cell anemia, where abnormally shaped red blood cells make blood thicker and increase organ stress. The device, presented in the Journal of Dynamic Systems, Measurement, and Control, runs primarily on software, meaning it can be implemented on low-cost hardware, allowing portable prototypes and future wearable integrations. The research team is now gathering data to support eventual human trials and hopes viscosity will become a new standard vital sign.

“Measuring blood viscosity has always been a challenge,” said Professor William Fay. “Specialized lab equipment is needed, and most hospitals don’t have it. This new device could be a game changer — it allows accurate, real-time viscosity readings without ever drawing blood.”

“This isn’t just a new device,” said Nilesh Salvi, lead author on the project. “It’s a new way of thinking about the human body. Once we can see viscosity in real time, we’ll understand blood flow and disease progression in ways we never could before.”

Related Links:
University of Missouri 


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.